The New York Genome Center spinout has been conducting a pilot project involving Oxford Nanopore's MinIon with a Manhattan middle school.
The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.
The centers are using the standardized pipeline to help streamline data sharing and data analysis to achieve their larger research goals.
The researchers applied their so-called GWAX approach to study 12 common diseases in almost 120,000 individuals, confirming known and uncovering novel disease risk loci.
The center plans to offer the test for patients with undiagnosed disease and for disease predisposition testing in ostensibly healthy individuals.
The partners have committed to analyzing coding mutations, driver non-coding mutations, and structural variations across tumor types for the project.
Seeq has much in common with DNA.Land, launched last year, but targets individuals who have not used services from direct-to-consumer testing companies
Data from 43 genome-wide association studies have led researchers to individual variants and genetic factors that influence multiple phenotypes and conditions.
The partners plan to build a comprehensive repository that will contain genomic, exome, and phenotype data collected first from about 200 cancer patients.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.
The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.
LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.